Supported By
Canadian Prostate Cancer Guide
Bringing you the most up to date information in treatments, support, well-being, and more all in one place.
Talking to Doctor Guides
Guides to prepare you for visits with your doctors and care team.
Webinars and Podcasts
Take your info on the go with our webinars and podcast section.
Support Groups
A coast to coast directory is available to help you find support in your area or online.
Patient Stories
Hear from other patients and caregivers about their experiences with prostate cancer. Share your story with us too!
About THIS SITE
We can help you in achieving the support you’re looking for. On the Canadian Prostate Cancer Guide website you can look to find the most up to date information on prostate cancer in one place.
The Canadian Cancer Survivor
Network (CCSN) has a long and established relationship with prostate cancer patients,
survivors, caregivers, and support groups. Indeed, CCSN was the recipient of
the Dried Prostate Award from Prostate Cancer Network Ottawa in 2014.
24, 600 men are diagnosed with prostate cancer annually in Canada, with a five-year net survival rate of 91%. Given its history in working in the prostate cancer field, CCSN in looking at taking a more active national role, including forging closer relationships with prostate cancer support groups across Canada and in building this website.
The Canadian Cancer Survivor Network (CCSN) is a leader in patient participation in healthcare, with a mandate to educate the public and policy makers about cancer survivorship and engage in and encourage research on ways to alleviate barriers to optimal cancer care in Canada.
CCSN is working to raise awareness about the importance of the early diagnosis of prostate cancer, including the need for formal prostate screening programs in every province and territory.
The Canadian Prostate Cancer Guide is yours to use and to improve. Send us your cancer journey story to be included on the site. Suggest patient and caregiver guides about how to talk to your healthcare team, or treatment guidelines you found useful. Suggest prostate cancer topics for webinars!
Jackie Manthorne
Featured Resources
2025 CCSN Golf Tournament
Canadian Cancer Survivor Network
We are so excited to be hosting our first fundraising golf tournament!
What can you expect?
To start – a great day! This is an opportunity to connect and learn. There will be patients, survivors, funders, support groups, advocates and others in attendance. What a great way to meet new people and see what we do.
It will be a noon shotgun start August 22nd, 2025 at Greensmere Golf and Country Club. Registration at 11:00am
$125.00 per player includes:
• 18 holes of golf
• Cart
• Lunch bag
• Hole contests
• Dinner
• Raffles & silent auctions
• A GREAT DAY!
Fill out the REGISTRATION FORM to sign your team up today!
August 22, 2025
August 22, 2025Butts in A Boat Prostate Cancer Survivor Dragon Boat Team by Jeff Greig
Butts in a Boat
Not only do participants enjoy participating in great physical activity, but the study also showed the positive impact on men’s psychosocial wellbeing as being even more important.
And to this I personally attest.
CCSN’s Prostate Cancer Focus Group Meeting
CCSN hosted a virtual prostate cancer patient focus group to gain insights on the experiences of individuals receiving treatment for prostate cancer, focusing on management approaches, side effects, and overall impact on quality of life. It was also discussed how we could identify strategies to optimize support for those living with prostate cancer.
pcpep.org – Patient Education and Empowerment Programs for Prostate Cancer Patients
Prostate Cancer Patient Empowerment Program
PC_PEP is an online intervention available across Canada for prostate cancer patients and caregivers. It features exercise videos, stress reduction techniques, dietary support and regular group videoconferences with mentors.
Lifestyle Management
True North
TrueNTH Lifestyle Management offers exercise and nutrition programs for prostate cancer patients and survivors. Community-based programs, home programs, and information resources are available.
Quebec implements public reimbursement of Pluvicto® – a defining milestone for radioligand therapy in Canada
Newswire
As of July 2, 2025, Pluvicto® (lutetium (177Lu) vipivotide tetraxetan injection) is publicly reimbursed in Quebec for eligible patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC).
Nova Scotia shows leadership in publicly reimbursing Pluvicto™ for eligible patients with advanced prostate cancer
Newswire
Effective February 1, 2025, Nova Scotia is publicly funding Pluvicto, a targeted radioligand therapy. -Published on February 3rd 2025
Alberta adding access to new type of prostate cancer screening
Edmonton Journal
Albertans will soon have access to a new, experimental kind of prostate cancer screening that promises to offer better results than typical testing. “It functions by creating images that use radioactive tracers to reveal tissue and organ function,” said Health Minister Adriana LaGrange in a news release Wednesday.
Analysis of findings from long-term study reveals more genetic mutations associated with aggressive prostate cancer
The Institute of Cancer Research
Scientists have added to the list of inherited genetic mutations known to increase the risk of more aggressive prostate cancer. This information could help with identifying prostate cancer patients who are more likely to experience rapid progression of the disease. - Published July 2nd 2024
XTANDI® (enzalutamide) now funded in Ontario for all approved prostate cancer indications
Newswire
Astellas Pharma Canada, Inc. announced that XTANDI® (enzalutamide) is now funded by the Ontario Drug Benefit Program under the Exceptional Access Program for the treatment of patients with non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence (BCR) at high risk of metastasis (high-risk BCR).i This decision means XTANDI is now publicly reimbursed in Ontario for all of its approved prostate cancer indications.